As general manager, Atwood will leverage sales and product management experience in the life sciences space to solidify Opentrons’ position as a leader in laboratory automation.

BROOKLYN, NY, April 12, 2023 – Opentrons Labworks, Inc., a life sciences company at the forefront of the Lab 4.0 movement, today announced the appointment of James Atwood as General Manager of its Opentrons Robotics business unit. Leveraging Atwood's expertise in genomics and laboratory research tool development, the company is well-positioned to expand commercialization of the OT-2 liquid handling robot and prepare for the next generation of advanced laboratory automation robots.

"We are delighted to welcome James during this exciting period of growth," said Jonathan Brennan-Badal, CEO of Opentrons. "James brings a wealth of experience as a business development manager with a demonstrated With his exceptional leadership skills and deep knowledge of sales and product management in the life sciences sector, he is truly a perfect addition to the Opentrons family.”

Prior to joining Opentrons, Atwood served as Vice President of the Omics Business Unit at MOBILion Systems, a genomics tools company. Previously, Atwood served as general manager of applied genomics at laboratory instrument company PerkinElmer, where he played a key role in developing and deploying innovative solutions for sample dissociation, liquid handling, microfluidics, nucleic acid extraction and NGS library preparation.

"Opentrons' unwavering commitment to changing the landscape of laboratory automation and making automation more accessible and equitable for all is not only inspiring but a testament to their visionary approach," Atwood said. By expanding access to groundbreaking research tools, they enable scientists and researchers around the world to push the boundaries of knowledge and discovery. I am incredibly proud and excited to join the Opentrons team for this extraordinary project that will truly shape the future of scientific innovation. Trying to contribute my skills and passion.”

About Opentrons Labworks, Inc.

Opentrons Labworks, Inc. is a disruptive life sciences company using its integrated laboratory platform to accelerate the pace of innovation in research and healthcare. Opentrons Labworks is the parent company of the Opentrons Robotics and Neochromosome business units. Through Opentrons Robotics, thousands of institutions are automating R&D operations with flexible, easy-to-use liquid handling laboratory robots. With Neochromosome, biopharmaceuticals and biotechnology can benefit from our world-class genome-scale cell engineering solutions. For more information, please visit https://www.opentronslabworks.com/.

Media Contact

open TR ONS@consort partners.com